BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vlodavsky I, Singh P, Boyango I, Gutter-Kapon L, Elkin M, Sanderson RD, Ilan N. Heparanase: From basic research to therapeutic applications in cancer and inflammation. Drug Resist Updat. 2016;29:54-75. [PMID: 27912844 DOI: 10.1016/j.drup.2016.10.001] [Cited by in Crossref: 113] [Cited by in F6Publishing: 111] [Article Influence: 18.8] [Reference Citation Analysis]
Number Citing Articles
1 Barash U, Spyrou A, Liu P, Vlodavsky E, Zhu C, Luo J, Su D, Ilan N, Forsberg‐nilsson K, Vlodavsky I, Yang X. Heparanase promotes glioma progression via enhancing CD24 expression. Int J Cancer 2019;145:1596-608. [DOI: 10.1002/ijc.32375] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
2 Zhu S, Li J, Loka RS, Song Z, Vlodavsky I, Zhang K, Nguyen HM. Modulating Heparanase Activity: Tuning Sulfation Pattern and Glycosidic Linkage of Oligosaccharides. J Med Chem 2020;63:4227-55. [PMID: 32216347 DOI: 10.1021/acs.jmedchem.0c00156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Liu J, Knani I, Gross-Cohen M, Hu J, Wang S, Tang L, Ilan N, Yang S, Vlodavsky I. Role of heparanase 2 (Hpa2) in gastric cancer. Neoplasia 2021;23:966-78. [PMID: 34343822 DOI: 10.1016/j.neo.2021.07.010] [Reference Citation Analysis]
4 Koganti R, Suryawanshi R, Shukla D. Heparanase, cell signaling, and viral infections. Cell Mol Life Sci 2020;77:5059-77. [PMID: 32462405 DOI: 10.1007/s00018-020-03559-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
5 Si J, Li W, Li X, Cao L, Chen Z, Jiang Z. Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma. Cancer Sci 2021;112:3491-506. [PMID: 34036683 DOI: 10.1111/cas.14984] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Suhovskih AV, Kazanskaya GM, Volkov AM, Tsidulko AY, Aidagulova SV, Grigorieva EV. Chemoradiotherapy Increases Intratumor Heterogeneity of HPSE Expression in the Relapsed Glioblastoma Tumors. Int J Mol Sci 2020;21:E1301. [PMID: 32075104 DOI: 10.3390/ijms21041301] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Katz A, Barash U, Boyango I, Feld S, Zohar Y, Hammond E, Ilan N, Kremer R, Vlodavsky I. Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer. Oncotarget 2018;9:19294-306. [PMID: 29721203 DOI: 10.18632/oncotarget.25022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
8 Sanderson RD, Bandari SK, Vlodavsky I. Proteases and glycosidases on the surface of exosomes: Newly discovered mechanisms for extracellular remodeling. Matrix Biol 2019;75-76:160-9. [PMID: 29106944 DOI: 10.1016/j.matbio.2017.10.007] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 13.2] [Reference Citation Analysis]
9 Koganti R, Memon A, Shukla D. Emerging Roles of Heparan Sulfate Proteoglycans in Viral Pathogenesis. Semin Thromb Hemost 2021;47:283-94. [PMID: 33851373 DOI: 10.1055/s-0041-1725068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Abassi Z, Hamoud S, Hassan A, Khamaysi I, Nativ O, Heyman SN, Muhammad RS, Ilan N, Singh P, Hammond E, Zaza G, Lupo A, Onisto M, Bellin G, Masola V, Vlodavsky I, Gambaro G. Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. Oncotarget 2017;8:34191-204. [PMID: 28388547 DOI: 10.18632/oncotarget.16573] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
11 Tang L, Tang B, Lei Y, Yang M, Wang S, Hu S, Xie Z, Liu Y, Vlodavsky I, Yang S. Helicobacter pylori-Induced Heparanase Promotes H. pylori Colonization and Gastritis. Front Immunol 2021;12:675747. [PMID: 34220822 DOI: 10.3389/fimmu.2021.675747] [Reference Citation Analysis]
12 Fu C, Yu Z, He Y, Ding J, Wei M. Down-Regulation of an Autophagy-Related Gene SERPINA1 as a Superior Prognosis Biomarker Associates with Relapse and Distant Metastasis in Colon Adenocarcinoma. Onco Targets Ther 2021;14:3861-72. [PMID: 34188492 DOI: 10.2147/OTT.S306405] [Reference Citation Analysis]
13 Gross-Cohen M, Yanku Y, Kessler O, Barash U, Boyango I, Cid-Arregui A, Neufeld G, Ilan N, Vlodavsky I. Heparanase 2 (Hpa2) attenuates tumor growth by inducing Sox2 expression. Matrix Biol 2021;99:58-71. [PMID: 34004353 DOI: 10.1016/j.matbio.2021.05.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Karamanos NK, Piperigkou Z, Passi A, Götte M, Rousselle P, Vlodavsky I. Extracellular matrix-based cancer targeting. Trends Mol Med 2021:S1471-4914(21)00190-8. [PMID: 34389240 DOI: 10.1016/j.molmed.2021.07.009] [Reference Citation Analysis]
15 Chen J, Kawamura T, Sethi MK, Zaia J, Repunte-Canonigo V, Sanna PP. Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse. Sci Rep 2017;7:13931. [PMID: 29066725 DOI: 10.1038/s41598-017-13960-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
16 Pinhal MAS, Melo CM, Nader HB. The Good and Bad Sides of Heparanase-1 and Heparanase-2. Adv Exp Med Biol 2020;1221:821-45. [PMID: 32274740 DOI: 10.1007/978-3-030-34521-1_36] [Reference Citation Analysis]
17 Barash U, Rangappa S, Mohan CD, Vishwanath D, Boyango I, Basappa B, Vlodavsky I, Rangappa KS. New Heparanase-Inhibiting Triazolo-Thiadiazoles Attenuate Primary Tumor Growth and Metastasis. Cancers (Basel) 2021;13:2959. [PMID: 34199150 DOI: 10.3390/cancers13122959] [Reference Citation Analysis]
18 Masola V, Zaza G, Bellin G, Dall'Olmo L, Granata S, Vischini G, Secchi MF, Lupo A, Gambaro G, Onisto M. Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury. FASEB J 2018;32:742-56. [PMID: 28970256 DOI: 10.1096/fj.201700597R] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
19 Weissmann M, Bhattacharya U, Feld S, Hammond E, Ilan N, Vlodavsky I. The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action. Matrix Biol 2019;77:58-72. [PMID: 30096360 DOI: 10.1016/j.matbio.2018.08.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
20 Tang B, Yang S. Involvement of Heparanase in Gastric Cancer Progression and Immunotherapy. Adv Exp Med Biol 2020;1221:351-63. [PMID: 32274717 DOI: 10.1007/978-3-030-34521-1_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Rangarajan S, Richter JR, Richter RP, Bandari SK, Tripathi K, Vlodavsky I, Sanderson RD. Heparanase-enhanced Shedding of Syndecan-1 and Its Role in Driving Disease Pathogenesis and Progression. J Histochem Cytochem 2020;68:823-40. [PMID: 32623935 DOI: 10.1369/0022155420937087] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
22 Mohan CD, Hari S, Preetham HD, Rangappa S, Barash U, Ilan N, Nayak SC, Gupta VK, Basappa, Vlodavsky I, Rangappa KS. Targeting Heparanase in Cancer: Inhibition by Synthetic, Chemically Modified, and Natural Compounds. iScience 2019;15:360-90. [PMID: 31103854 DOI: 10.1016/j.isci.2019.04.034] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 10.7] [Reference Citation Analysis]
23 Capozzi A, Riitano G, Recalchi S, Manganelli V, Costi R, Saccoliti F, Pulcinelli F, Garofalo T, Misasi R, Longo A, Di Santo R, Sorice M. Effect of heparanase inhibitor on tissue factor overexpression in platelets and endothelial cells induced by anti-β2-GPI antibodies. J Thromb Haemost 2021;19:2302-13. [PMID: 34107171 DOI: 10.1111/jth.15417] [Reference Citation Analysis]
24 Wagner MFMG, Theodoro TR, Filho CASM, Oyafuso LKM, Pinhal MAS. Extracellular matrix alterations in the skin of patients affected by psoriasis. BMC Mol Cell Biol 2021;22:55. [PMID: 34715781 DOI: 10.1186/s12860-021-00395-1] [Reference Citation Analysis]
25 Lupu F, Kinasewitz G, Dormer K. The role of endothelial shear stress on haemodynamics, inflammation, coagulation and glycocalyx during sepsis. J Cell Mol Med 2020;24:12258-71. [PMID: 32951280 DOI: 10.1111/jcmm.15895] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
26 Singh M, Watkinson M, Scanlan EM, Miller GJ. Illuminating glycoscience: synthetic strategies for FRET-enabled carbohydrate active enzyme probes. RSC Chem Biol 2020;1:352-68. [DOI: 10.1039/d0cb00134a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Cassinelli G, Dal Bo L, Favini E, Cominetti D, Pozzi S, Tortoreto M, De Cesare M, Lecis D, Scanziani E, Minoli L, Naggi A, Vlodavsky I, Zaffaroni N, Lanzi C. Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases. Cancer Lett 2018;415:187-97. [PMID: 29225052 DOI: 10.1016/j.canlet.2017.12.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
28 Gopal S, Arokiasamy S, Pataki C, Whiteford JR, Couchman JR. Syndecan receptors: pericellular regulators in development and inflammatory disease. Open Biol 2021;11:200377. [PMID: 33561383 DOI: 10.1098/rsob.200377] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
29 Ostrovsky O, Vlodavsky I, Nagler A. Mechanism of HPSE Gene SNPs Function: From Normal Processes to Inflammation, Cancerogenesis and Tumor Progression. Adv Exp Med Biol 2020;1221:231-49. [PMID: 32274712 DOI: 10.1007/978-3-030-34521-1_8] [Reference Citation Analysis]
30 Tan YX, Cui H, Wan LM, Gong F, Zhang X, Vlodavsky I, Li JP. Overexpression of heparanase in mice promoted megakaryopoiesis. Glycobiology 2018;28:269-75. [PMID: 29471321 DOI: 10.1093/glycob/cwy011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
31 Bendersky V, Yang Y, Brennan TV. Immunomodulatory Activities of the Heparan Sulfate Mimetic PG545. Adv Exp Med Biol 2020;1221:461-70. [PMID: 32274722 DOI: 10.1007/978-3-030-34521-1_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
32 Lin P, He Y, Wen DY, Li XJ, Zeng JJ, Mo WJ, Li Q, Peng JB, Wu YQ, Pan DH, Li HY, Mo QY, Wei YP, Yang H, Chen G. Comprehensive analysis of the clinical significance and prospective molecular mechanisms of differentially expressed autophagy-related genes in thyroid cancer. Int J Oncol 2018;53:603-19. [PMID: 29749543 DOI: 10.3892/ijo.2018.4404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
33 Zhang Y, Qu X, Jiang L. An oasis in the desert of cancer chemotherapeutic resistance: The enlightenment from reciprocal crosstalk between signaling pathways of UPR and autophagy in cancers. Biomedicine & Pharmacotherapy 2017;92:972-81. [DOI: 10.1016/j.biopha.2017.05.132] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
34 Mayfosh AJ, Nguyen TK, Hulett MD. The Heparanase Regulatory Network in Health and Disease. Int J Mol Sci 2021;22:11096. [PMID: 34681753 DOI: 10.3390/ijms222011096] [Reference Citation Analysis]
35 Vlodavsky I, Gross-Cohen M, Weissmann M, Ilan N, Sanderson RD. Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression. Trends Biochem Sci 2018;43:18-31. [PMID: 29162390 DOI: 10.1016/j.tibs.2017.10.007] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 15.6] [Reference Citation Analysis]
36 Ilan N, Bhattacharya U, Barash U, Boyango I, Yanku Y, Gross-cohen M, Vlodavsky I. Heparanase-The Message Comes in Different Flavors. In: Vlodavsky I, Sanderson RD, Ilan N, editors. Heparanase. Cham: Springer International Publishing; 2020. pp. 253-83. [DOI: 10.1007/978-3-030-34521-1_9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
37 Kayal Y, Singh P, Naroditsky I, Ilan N, Vlodavsky I. Heparanase 2 (Hpa2) attenuates the growth of pancreatic carcinoma. Matrix Biol 2021;98:21-31. [PMID: 33839221 DOI: 10.1016/j.matbio.2021.03.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
38 Tzanakakis G, Neagu M, Tsatsakis A, Nikitovic D. Proteoglycans and Immunobiology of Cancer-Therapeutic Implications. Front Immunol 2019;10:875. [PMID: 31068944 DOI: 10.3389/fimmu.2019.00875] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
39 Zhao W, Wang W, Li X, Liu Y, Gao H, Jiang Y, Wang Y. Peripheral neuropathy following bortezomib therapy in multiple myeloma patients: association with cumulative dose, heparanase, and TNF-α. Ann Hematol 2019;98:2793-803. [PMID: 31650289 DOI: 10.1007/s00277-019-03816-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
40 Secchi MF, Crescenzi M, Masola V, Russo FP, Floreani A, Onisto M. Heparanase and macrophage interplay in the onset of liver fibrosis. Sci Rep 2017;7:14956. [PMID: 29097791 DOI: 10.1038/s41598-017-14946-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
41 Lanzi C, Cassinelli G. Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunities. Biochemical Pharmacology 2020;178:114084. [DOI: 10.1016/j.bcp.2020.114084] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
42 Hoffmann R, Sarkar Bhattacharya S, Roy D, Winterhoff B, Schmidmaier R, Dredge K, Hammond E, Shridhar V. Sulfated glycolipid PG545 induces endoplasmic reticulum stress and augments autophagic flux by enhancing anticancer chemotherapy efficacy in endometrial cancer. Biochem Pharmacol 2020;178:114003. [PMID: 32360360 DOI: 10.1016/j.bcp.2020.114003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Khanna M, Parish CR. Heparanase: Historical Aspects and Future Perspectives. Adv Exp Med Biol 2020;1221:71-96. [PMID: 32274707 DOI: 10.1007/978-3-030-34521-1_3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
44 Schwarz S, Gockel LM, Naggi A, Barash U, Gobec M, Bendas G, Schlesinger M. Glycosaminoglycans as Tools to Decipher the Platelet Tumor Cell Interaction: A Focus on P-Selectin. Molecules 2020;25:E1039. [PMID: 32110917 DOI: 10.3390/molecules25051039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
45 Icard P, Simula L, Wu Z, Berzan D, Sogni P, Dohan A, Dautry R, Coquerel A, Lincet H, Loi M, Fuks D. Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma? Drug Resist Updat 2021;:100790. [PMID: 34924279 DOI: 10.1016/j.drup.2021.100790] [Reference Citation Analysis]
46 Zhang X, Wang Y, Xie M, Corbett C, Singhal S, Dai B, Wang J, Ding Q, Lu Q, Wang Y. Downregulating Heparanase-Induced Vascular Normalization: A New Approach To Increase the Bioavailability of Chemotherapeutics in Solid Tumors. Mol Pharm 2018;15:4303-9. [PMID: 30059227 DOI: 10.1021/acs.molpharmaceut.8b00628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
47 Khamaysi I, Singh P, Nasser S, Awad H, Chowers Y, Sabo E, Hammond E, Gralnek I, Minkov I, Noseda A, Ilan N, Vlodavsky I, Abassi Z. The Role of Heparanase in the Pathogenesis of Acute Pancreatitis: A Potential Therapeutic Target. Sci Rep 2017;7:715. [PMID: 28386074 DOI: 10.1038/s41598-017-00715-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
48 Purushothaman A, Sanderson RD. Heparanase: A Dynamic Promoter of Myeloma Progression. Adv Exp Med Biol 2020;1221:331-49. [PMID: 32274716 DOI: 10.1007/978-3-030-34521-1_12] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
49 Lanzi C, Cassinelli G. Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity. Molecules 2018;23:E2915. [PMID: 30413079 DOI: 10.3390/molecules23112915] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
50 Abdi E, Latifi-Navid S, Abedi Sarvestani F, Esmailnejad MH. Emerging therapeutic targets for gastric cancer from a host-Helicobacter pylori interaction perspective. Expert Opin Ther Targets 2021;25:685-99. [PMID: 34410200 DOI: 10.1080/14728222.2021.1971195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
51 Yu S, Lv H, Zhang H, Jiang Y, Hong Y, Xia R, Zhang Q, Ju W, Jiang L, Ou G, Zhang J, Wang S, Zhang J. Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK pathway. Biochemical and Biophysical Research Communications 2017;485:432-9. [DOI: 10.1016/j.bbrc.2017.02.060] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
52 Sletten ET, Loka RS, Yu F, Nguyen HM. Glycosidase Inhibition by Multivalent Presentation of Heparan Sulfate Saccharides on Bottlebrush Polymers. Biomacromolecules 2017;18:3387-99. [PMID: 28846389 DOI: 10.1021/acs.biomac.7b01049] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
53 Tripathi K, Ramani VC, Bandari SK, Amin R, Brown EE, Ritchie JP, Stewart MD, Sanderson RD. Heparanase promotes myeloma stemness and in vivo tumorigenesis. Matrix Biol 2020;88:53-68. [PMID: 31812535 DOI: 10.1016/j.matbio.2019.11.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
54 Bandari SK, Tripathi K, Rangarajan S, Sanderson RD. Therapy-induced chemoexosomes: Sinister small extracellular vesicles that support tumor survival and progression. Cancer Lett 2020;493:113-9. [PMID: 32858103 DOI: 10.1016/j.canlet.2020.08.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Xiang J, Lu M, Shi M, Cheng X, Kwakwa KA, Davis JL, Su X, Bakewell SJ, Zhang Y, Fontana F, Xu Y, Veis DJ, DiPersio JF, Ratner L, Sanderson RD, Noseda A, Mollah S, Li J, Weilbaecher KN. Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19. J Virol 2022;:e0005722. [PMID: 35319225 DOI: 10.1128/jvi.00057-22] [Reference Citation Analysis]
56 Fu K, Bai Z, Chen L, Ye W, Wang M, Hu J, Liu C, Zhou W. Antitumor activity and structure-activity relationship of heparanase inhibitors: Recent advances. Eur J Med Chem 2020;193:112221. [PMID: 32222663 DOI: 10.1016/j.ejmech.2020.112221] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
57 Noseda A, Barbieri P. Roneparstat: Development, Preclinical and Clinical Studies. Adv Exp Med Biol 2020;1221:523-38. [PMID: 32274725 DOI: 10.1007/978-3-030-34521-1_21] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
58 Jiang XZ, Goligorsky MS, Luo KH. Cross talk between endothelial and red blood cell glycocalyces via near-field flow. Biophys J 2021;120:3180-91. [PMID: 34197803 DOI: 10.1016/j.bpj.2021.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Berdiaki A, Neagu M, Giatagana EM, Kuskov A, Tsatsakis AM, Tzanakakis GN, Nikitovic D. Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy. Biomolecules 2021;11:395. [PMID: 33800172 DOI: 10.3390/biom11030395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Khamaysi I, Hamo-Giladi DB, Abassi Z. Heparanase in Acute Pancreatitis. Adv Exp Med Biol 2020;1221:703-19. [PMID: 32274733 DOI: 10.1007/978-3-030-34521-1_29] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Karamanos NK, Piperigkou Z, Theocharis AD, Watanabe H, Franchi M, Baud S, Brézillon S, Götte M, Passi A, Vigetti D, Ricard-blum S, Sanderson RD, Neill T, Iozzo RV. Proteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and Therapeutics. Chem Rev 2018;118:9152-232. [DOI: 10.1021/acs.chemrev.8b00354] [Cited by in Crossref: 136] [Cited by in F6Publishing: 130] [Article Influence: 34.0] [Reference Citation Analysis]
62 Zhang GL, Gutter-Kapon L, Ilan N, Batool T, Singh K, Digre A, Luo Z, Sandler S, Shaked Y, Sanderson RD, Wang XM, Li JP, Vlodavsky I. Significance of host heparanase in promoting tumor growth and metastasis.Matrix Biol. 2020;93:25-42. [PMID: 32534153 DOI: 10.1016/j.matbio.2020.06.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
63 Lapidot M, Barash U, Vlodavsky I, Pass H. Heparanase inhibitors restrain mesothelioma. Oncotarget 2018;9:36830-2. [PMID: 30627323 DOI: 10.18632/oncotarget.26243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
64 Bhattacharya U, Gutter-Kapon L, Kan T, Boyango I, Barash U, Yang SM, Liu J, Gross-Cohen M, Sanderson RD, Shaked Y, Ilan N, Vlodavsky I. Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth. Cancer Res 2020;80:57-68. [PMID: 31690669 DOI: 10.1158/0008-5472.CAN-19-1676] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
65 Bendas G, Borsig L. Heparanase in Cancer Metastasis – Heparin as a Potential Inhibitor of Cell Adhesion Molecules. In: Vlodavsky I, Sanderson RD, Ilan N, editors. Heparanase. Cham: Springer International Publishing; 2020. pp. 309-29. [DOI: 10.1007/978-3-030-34521-1_11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
66 Goligorsky MS, Sun D. Glycocalyx in Endotoxemia and Sepsis. Am J Pathol 2020;190:791-8. [PMID: 32035882 DOI: 10.1016/j.ajpath.2019.06.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
67 Chen X, Cheng B, Dai D, Wu Y, Feng Z, Tong C, Wang X, Zhao J. Heparanase induces necroptosis of microvascular endothelial cells to promote the metastasis of hepatocellular carcinoma. Cell Death Discov 2021;7:33. [PMID: 33597510 DOI: 10.1038/s41420-021-00411-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
68 Bartolini B, Caravà E, Caon I, Parnigoni A, Moretto P, Passi A, Vigetti D, Viola M, Karousou E. Heparan Sulfate in the Tumor Microenvironment. Adv Exp Med Biol 2020;1245:147-61. [PMID: 32266657 DOI: 10.1007/978-3-030-40146-7_7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
69 Furini S, Falciani C. Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer. Front Oncol 2021;11:695858. [PMID: 34249755 DOI: 10.3389/fonc.2021.695858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Ben-Zvi M, Herman HG, Schreiber L, Sagiv R, Bar J, Condrea A, Ginath S. Expression of Heparanase in uterosacral ligaments of women with or without uterine prolapse. Eur J Obstet Gynecol Reprod Biol 2020;244:110-3. [PMID: 31785466 DOI: 10.1016/j.ejogrb.2019.11.024] [Reference Citation Analysis]
71 Wieboldt R, Läubli H. Glycosoaminoglycans in cancer therapy. Am J Physiol Cell Physiol 2022. [PMID: 35385322 DOI: 10.1152/ajpcell.00063.2022] [Reference Citation Analysis]
72 Gockel LM, Heyes M, Li H, Al Nahain A, Gorzelanny C, Schlesinger M, Holdenrieder S, Li JP, Ferro V, Bendas G. Inhibition of Tumor-Host Cell Interactions Using Synthetic Heparin Mimetics. ACS Appl Mater Interfaces 2021;13:7080-93. [PMID: 33533245 DOI: 10.1021/acsami.0c20744] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
73 Boyango I, Barash U, Fux L, Naroditsky I, Ilan N, Vlodavsky I. Targeting heparanase to the mammary epithelium enhances mammary gland development and promotes tumor growth and metastasis. Matrix Biol 2018;65:91-103. [PMID: 28916201 DOI: 10.1016/j.matbio.2017.08.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
74 El-Nadi M, Hassan H, Saleh ME, Nassar E, Ismail YM, Amer M, Greve B, Götte M, El-Shinawi M, Ibrahim SA. Induction of heparanase via IL-10 correlates with a high infiltration of CD163+ M2-type tumor-associated macrophages in inflammatory breast carcinomas. Matrix Biol Plus 2020;6-7:100030. [PMID: 33543027 DOI: 10.1016/j.mbplus.2020.100030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
75 Mayfosh AJ, Baschuk N, Hulett MD. Leukocyte Heparanase: A Double-Edged Sword in Tumor Progression. Front Oncol 2019;9:331. [PMID: 31110966 DOI: 10.3389/fonc.2019.00331] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
76 Wu L, Dell'Anno I, Lapidot M, Sekido Y, Chan ML, Kohno M, Serre-Beinier V, Felley-Bosco E, de Perrot M. Progress of malignant mesothelioma research in basic science: A review of the 14th international conference of the international mesothelioma interest group (iMig2018). Lung Cancer 2019;127:138-45. [PMID: 30642542 DOI: 10.1016/j.lungcan.2018.11.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
77 Kong F, Zhang R, Zhao X, Zheng G, Wang Z, Wang P. Resveratrol raises in vitro anticancer effects of paclitaxel in NSCLC cell line A549 through COX-2 expression. Korean J Physiol Pharmacol 2017;21:465-74. [PMID: 28883751 DOI: 10.4196/kjpp.2017.21.5.465] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
78 Katakam SK, Pelucchi P, Cocola C, Reinbold R, Vlodavsky I, Greve B, Götte M. Syndecan-1-Dependent Regulation of Heparanase Affects Invasiveness, Stem Cell Properties, and Therapeutic Resistance of Caco2 Colon Cancer Cells. Front Oncol 2020;10:774. [PMID: 32477959 DOI: 10.3389/fonc.2020.00774] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
79 Chen X, Ye R, Dai D, Wu Y, Yu Y, Cheng B. [Heparanase promotes trans-endothelial migration of hepatocarcinoma cells by inducing apoptosis of microvascular endothelial cells]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:1065-71. [PMID: 32895190 DOI: 10.12122/j.issn.1673-4254.2020.08.01] [Reference Citation Analysis]
80 Loka RS, Sletten ET, Barash U, Vlodavsky I, Nguyen HM. Specific Inhibition of Heparanase by a Glycopolymer with Well-Defined Sulfation Pattern Prevents Breast Cancer Metastasis in Mice. ACS Appl Mater Interfaces 2019;11:244-54. [PMID: 30543095 DOI: 10.1021/acsami.8b17625] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
81 Wu W, Zhao L, Yu Y, Hu H, Shi H, Jia Q, Du L. Heparanase expression in blood is sensitive to monitor response to anticancer treatment in pancreatic cancer, a pilot study. Pancreatology 2018;18:100-5. [PMID: 29153700 DOI: 10.1016/j.pan.2017.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
82 Gross-Cohen M, Feld S, Arvatz G, Ilan N, Vlodavsky I. Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2. Front Oncol 2020;10:627463. [PMID: 33585253 DOI: 10.3389/fonc.2020.627463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Wang F, Pulinilkunnil T, Flibotte S, Nislow C, Vlodavsky I, Hussein B, Rodrigues B. Heparanase protects the heart against chemical or ischemia/reperfusion injury. J Mol Cell Cardiol 2019;131:29-40. [PMID: 31004678 DOI: 10.1016/j.yjmcc.2019.04.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
84 Van Bergen T, Etienne I, Jia J, Li JP, Vlodavsky I, Stitt A, Vermassen E, Feyen JHM. Heparanase Deficiency Is Associated with Disruption, Detachment, and Folding of the Retinal Pigment Epithelium. Curr Eye Res 2021;46:1166-70. [PMID: 33372561 DOI: 10.1080/02713683.2020.1862239] [Reference Citation Analysis]
85 Huang Y, Deng X, Liang J. Review of the Application of Nanovesicles and the Human Interstitial Fluid in Gastrointestinal Premalignant Lesion Detection, Diagnosis, Prognosis and Therapy. Int J Nanomedicine 2019;14:9469-82. [PMID: 31819444 DOI: 10.2147/IJN.S208559] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
86 Pala D, Scalvini L, Elisi GM, Lodola A, Mor M, Spadoni G, Ferrara FF, Pavoni E, Roscilli G, Milazzo FM, Battistuzzi G, Rivara S, Giannini G. New classes of potent heparanase inhibitors from ligand-based virtual screening. J Enzyme Inhib Med Chem 2020;35:1685-96. [PMID: 32907434 DOI: 10.1080/14756366.2020.1811701] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
87 Annaval T, Wild R, Crétinon Y, Sadir R, Vivès RR, Lortat-Jacob H. Heparan Sulfate Proteoglycans Biosynthesis and Post Synthesis Mechanisms Combine Few Enzymes and Few Core Proteins to Generate Extensive Structural and Functional Diversity. Molecules 2020;25:E4215. [PMID: 32937952 DOI: 10.3390/molecules25184215] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
88 Hammond E, Haynes NM, Cullinane C, Brennan TV, Bampton D, Handley P, Karoli T, Lanksheer F, Lin L, Yang Y, Dredge K. Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors. J Immunother Cancer 2018;6:54. [PMID: 29898788 DOI: 10.1186/s40425-018-0363-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
89 Cohen-Kaplan V, Ilan N, Vlodavsky I. Heparanase Loosens E-Cadherin-Mediated Cell-Cell Contact via Activation of Src. Front Oncol 2020;10:2. [PMID: 32038981 DOI: 10.3389/fonc.2020.00002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Elli S, Stancanelli E, Handley PN, Carroll A, Urso E, Guerrini M, Ferro V. Structural and conformational studies of the heparan sulfate mimetic PI-88. Glycobiology 2018;28:731-40. [DOI: 10.1093/glycob/cwy068] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
91 Ostrovsky O, Baryakh P, Morgulis Y, Mayorov M, Bloom N, Beider K, Shimoni A, Vlodavsky I, Nagler A. The HPSE Gene Insulator-A Novel Regulatory Element That Affects Heparanase Expression, Stem Cell Mobilization, and the Risk of Acute Graft versus Host Disease. Cells 2021;10:2523. [PMID: 34685503 DOI: 10.3390/cells10102523] [Reference Citation Analysis]
92 Song T, Spillmann D. Transcriptomic analysis reveals cell apoptotic signature modified by heparanase in melanoma cells. J Cell Mol Med 2019;23:4559-68. [PMID: 31044520 DOI: 10.1111/jcmm.14349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
93 Ghiselli G. Heparin Binding Proteins as Therapeutic Target: An Historical Account and Current Trends. Medicines (Basel) 2019;6:E80. [PMID: 31362364 DOI: 10.3390/medicines6030080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
94 Gockel LM, Ponert JM, Schwarz S, Schlesinger M, Bendas G. The Low Molecular Weight Heparin Tinzaparin Attenuates Platelet Activation in Terms of Metastatic Niche Formation by Coagulation-Dependent and Independent Pathways. Molecules 2018;23:E2753. [PMID: 30356007 DOI: 10.3390/molecules23112753] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
95 Knani I, Singh P, Gross-Cohen M, Aviram S, Ilan N, Sanderson RD, Aronheim A, Vlodavsky I. Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3. Matrix Biol 2021:S0945-053X(21)00105-0. [PMID: 34808335 DOI: 10.1016/j.matbio.2021.11.001] [Reference Citation Analysis]
96 Cassinelli G, Torri G, Naggi A. Non-Anticoagulant Heparins as Heparanase Inhibitors. Adv Exp Med Biol 2020;1221:493-522. [PMID: 32274724 DOI: 10.1007/978-3-030-34521-1_20] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
97 Hadigal S, Koganti R, Yadavalli T, Agelidis A, Suryawanshi R, Shukla D. Heparanase-Regulated Syndecan-1 Shedding Facilitates Herpes Simplex Virus 1 Egress. J Virol 2020;94:e01672-19. [PMID: 31827001 DOI: 10.1128/JVI.01672-19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
98 Zhang Y, Xu F, Guan L, Chen M, Zhao Y, Guo L, Li X, Zheng Y, Gao A, Li S. Histone H4 induces heparan sulfate degradation by activating heparanase in chlorine gas-induced acute respiratory distress syndrome. Respir Res 2022;23:14. [PMID: 35073921 DOI: 10.1186/s12931-022-01932-y] [Reference Citation Analysis]
99 Li QW, Zhang GL, Hao CX, Ma YF, Sun X, Zhang Y, Cao KX, Li BX, Yang GW, Wang XM. SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer. J Ethnopharmacol 2021;266:113430. [PMID: 33011366 DOI: 10.1016/j.jep.2020.113430] [Reference Citation Analysis]
100 Veraldi N, Zouggari N, de Agostini A. The Challenge of Modulating Heparan Sulfate Turnover by Multitarget Heparin Derivatives. Molecules 2020;25:E390. [PMID: 31963505 DOI: 10.3390/molecules25020390] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
101 Bandari SK, Purushothaman A, Ramani VC, Brinkley GJ, Chandrashekar DS, Varambally S, Mobley JA, Zhang Y, Brown EE, Vlodavsky I, Sanderson RD. Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior. Matrix Biol 2018;65:104-18. [PMID: 28888912 DOI: 10.1016/j.matbio.2017.09.001] [Cited by in Crossref: 102] [Cited by in F6Publishing: 108] [Article Influence: 20.4] [Reference Citation Analysis]
102 Elli S, Guerrini M. Molecular Aspects of Heparanase Interaction with Heparan Sulfate, Heparin and Glycol Split Heparin. Adv Exp Med Biol 2020;1221:169-88. [PMID: 32274710 DOI: 10.1007/978-3-030-34521-1_6] [Reference Citation Analysis]
103 Vlodavsky I, Ilan N, Sanderson RD. Forty Years of Basic and Translational Heparanase Research. Adv Exp Med Biol 2020;1221:3-59. [PMID: 32274705 DOI: 10.1007/978-3-030-34521-1_1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
104 Wang Z, Xu Y, Wu G, Zuo T, Zhang J, Yang J, Yang Y, Fang T, Shen Q. Dual-Responsive and Deep-Penetrating Nanomicelles for Tumor Therapy via Extracellular Matrix Degradation and Oxidative Stress. ACS Biomater Sci Eng 2021;7:166-79. [PMID: 33372514 DOI: 10.1021/acsbiomaterials.0c01394] [Reference Citation Analysis]
105 Loka RS, Yu F, Sletten ET, Nguyen HM. Design, synthesis, and evaluation of heparan sulfate mimicking glycopolymers for inhibiting heparanase activity. Chem Commun (Camb) 2017;53:9163-6. [PMID: 28766595 DOI: 10.1039/c7cc04156j] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 6.8] [Reference Citation Analysis]
106 Liu LP, Sheng XP, Shuai TK, Zhao YX, Li B, Li YM. Helicobacter pylori promotes invasion and metastasis of gastric cancer by enhancing heparanase expression. World J Gastroenterol 2018; 24(40): 4565-4577 [PMID: 30386106 DOI: 10.3748/wjg.v24.i40.4565] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
107 Lei Y, Tang L, Liu S, Hu S, Wu L, Liu Y, Yang M, Huang S, Tang X, Tang T, Zhao X, Vlodavsky I, Zeng S, Tang B, Yang S. Parabacteroides produces acetate to alleviate heparanase-exacerbated acute pancreatitis through reducing neutrophil infiltration. Microbiome 2021;9:115. [PMID: 34016163 DOI: 10.1186/s40168-021-01065-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Parate S, Kumar V, Danishuddin, Hong JC, Lee KW. Computational Investigation Identified Potential Chemical Scaffolds for Heparanase as Anticancer Therapeutics. Int J Mol Sci 2021;22:5311. [PMID: 34156395 DOI: 10.3390/ijms22105311] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
109 Abassi Z, Goligorsky MS. Heparanase in Acute Kidney Injury. Adv Exp Med Biol 2020;1221:685-702. [PMID: 32274732 DOI: 10.1007/978-3-030-34521-1_28] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
110 Ntellas P, Perivoliotis K, Dadouli K, Koukoulis GK, Ioannou M. Microvessel Density as a Surrogate Prognostic Marker in Patients with Multiple Myeloma: A Meta-Analysis. Acta Haematol 2017;138:77-84. [PMID: 28796988 DOI: 10.1159/000478085] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
111 Ghoti H, Ackerman S, Rivella S, Casu C, Nadir Y. Heparanase Level and Procoagulant Activity Are Increased in Thalassemia and Attenuated by Janus Kinase 2 Inhibition. Am J Pathol 2020;190:2146-54. [PMID: 32745462 DOI: 10.1016/j.ajpath.2020.07.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 Zhou L, Yin R, Gao N, Sun H, Chen D, Cai Y, Ren L, Yang L, Zuo Z, Zhang H, Zhao J. Oligosaccharides from fucosylated glycosaminoglycan prevent breast cancer metastasis in mice by inhibiting heparanase activity and angiogenesis. Pharmacol Res 2021;166:105527. [PMID: 33667689 DOI: 10.1016/j.phrs.2021.105527] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
113 Rahat MA. Targeting Angiogenesis With Peptide Vaccines. Front Immunol 2019;10:1924. [PMID: 31440262 DOI: 10.3389/fimmu.2019.01924] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
114 Wang C, Wei Y, Wang G, Zhou Y, Zhang J, Xu K. Heparanase potentiates the invasion and migration of pancreatic cancer cells via epithelial‑to‑mesenchymal transition through the Wnt/β‑catenin pathway. Oncol Rep 2020;44:711-21. [PMID: 32627022 DOI: 10.3892/or.2020.7641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
115 Chhabra M, Ferro V. The Development of Assays for Heparanase Enzymatic Activity: Towards a Gold Standard. Molecules 2018;23:E2971. [PMID: 30441818 DOI: 10.3390/molecules23112971] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
116 Margulis I, Naroditsky I, Gross-Cohen M, Ilan N, Vlodavsky I, Doweck I. A Pro-Tumorigenic Effect of Heparanase 2 (Hpa2) in Thyroid Carcinoma Involves Its Localization to the Nuclear Membrane. Front Oncol 2021;11:645524. [PMID: 33959505 DOI: 10.3389/fonc.2021.645524] [Reference Citation Analysis]
117 Masola V, Bellin G, Gambaro G, Onisto M. Heparanase: A Multitasking Protein Involved in Extracellular Matrix (ECM) Remodeling and Intracellular Events. Cells 2018;7:E236. [PMID: 30487472 DOI: 10.3390/cells7120236] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
118 Ostrovsky O, Grushchenko-Polaq AH, Beider K, Mayorov M, Canaani J, Shimoni A, Vlodavsky I, Nagler A. Identification of strong intron enhancer in the heparanase gene: effect of functional rs4693608 variant on HPSE enhancer activity in hematological and solid malignancies. Oncogenesis 2018;7:51. [PMID: 29955035 DOI: 10.1038/s41389-018-0060-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
119 Mueller T, Pfankuchen DB, Wantoch von Rekowski K, Schlesinger M, Reipsch F, Bendas G. The Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers-Preclinical In Vivo Evaluation in Xenograft Tumor Models. Molecules 2017;22:E728. [PMID: 28467373 DOI: 10.3390/molecules22050728] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
120 Galli M, Chatterjee M, Grasso M, Specchia G, Magen H, Einsele H, Celeghini I, Barbieri P, Paoletti D, Pace S, Sanderson RD, Rambaldi A, Nagler A. Phase I study of the heparanase inhibitor roneparstat: an innovative approach for ultiple myeloma therapy. Haematologica 2018;103:e469-72. [PMID: 29700168 DOI: 10.3324/haematol.2017.182865] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 14.3] [Reference Citation Analysis]
121 Masola V, Zaza G, Gambaro G, Franchi M, Onisto M. Role of heparanase in tumor progression: Molecular aspects and therapeutic options. Semin Cancer Biol 2020;62:86-98. [PMID: 31348993 DOI: 10.1016/j.semcancer.2019.07.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]